Digital nanotechnologies for profiling trace immune dysregulations and tissue damage in emerging diseases

Regulation of the human immune system is a finely balanced process, and any immune dysregulations, even mild chronic inflammation, can have detrimental effects on health and quality of life. This project aims to develop breakthrough biomedical technologies to investigate the origins and temporal development of immune dysregulations in cancer therapy, COVID-19, and tissue damage. Leveraging longitudinal patient cohorts and pre-clinical models, the project will develop and utilise breakthrough biomedical technologies and state-of-the art molecular methods to deepen our understanding of immune dysregulation.

Our interdisciplinary team, led by Dr Alain Wuethrich, is seeking passionate and motivated PhD scholars to join us in unlocking the transformative potential of this technology. Interested students will have the opportunity to learn a variety of skills across a broad set of fields - including biomedical engineering, molecular biology, and clinical sciences.

View this project on the UQ Grad School website